ARALEZ PHARMACEUTICALS INC. Pre-Tax Income
ARALEZ PHARMACEUTICALS INC. reported Pre-Tax Income of -$20.94 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Income Statement
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2018-05-08
- ARALEZ PHARMACEUTICALS INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2018-03-31 was -$20.94M.
- ARALEZ PHARMACEUTICALS INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2017-12-31 was -$44.68M.
- ARALEZ PHARMACEUTICALS INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2017-09-30 was -$24.16M.
- ARALEZ PHARMACEUTICALS INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2017-06-30 was -$27.04M.
- ARALEZ PHARMACEUTICALS INC. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2017 was -$122.81M.
- ARALEZ PHARMACEUTICALS INC. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2016 was -$103.04M.
- ARALEZ PHARMACEUTICALS INC. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2015 was -$37.61M, a 291.15% decline from fiscal 2014.
- ARALEZ PHARMACEUTICALS INC. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2014 was $19.68M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2018-03-31 | -$20.94M 10-Q · filed 2018-05-08 | -$65.62M derived: sum of 2 quarters · filed 2018-05-08 | -$89.78M derived: sum of 3 quarters · filed 2018-05-08 | -$116.82M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-12-31 | -$44.68M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -$68.84M derived: sum of 2 quarters · filed 2018-03-14 | -$95.88M derived: sum of 3 quarters · filed 2018-03-14 | -$122.81M 10-K · filed 2018-03-14 |
| 2017-09-30 | -$24.16M 10-Q · filed 2017-11-09 | -$51.20M derived: sum of 2 quarters · filed 2017-11-09 | -$78.12M 10-Q · filed 2017-11-09 | -$109.75M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-06-30 | -$27.04M 10-Q · filed 2017-08-09 | -$53.96M 10-Q · filed 2017-08-09 | -$85.58M derived: sum of 3 quarters · filed 2018-05-08 | -$105.89M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-03-31 | -$26.93M 10-Q · filed 2018-05-08 | -$58.55M derived: sum of 2 quarters · filed 2018-05-08 | -$78.85M derived: sum of 3 quarters · filed 2018-05-08 | -$96.83M derived: sum of 4 quarters · filed 2018-05-08 |
| 2016-12-31 | -$31.62M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -$51.92M derived: sum of 2 quarters · filed 2018-03-14 | -$69.91M derived: sum of 3 quarters · filed 2018-03-14 | -$103.04M 10-K · filed 2018-03-14 |
| 2016-09-30 | -$20.30M 10-Q · filed 2017-11-09 | -$38.29M derived: sum of 2 quarters · filed 2017-11-09 | -$71.42M 10-Q · filed 2017-11-09 | -$85.55M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-06-30 | -$17.98M 10-Q · filed 2017-08-09 | -$51.12M 10-Q · filed 2017-08-09 | -$65.24M derived: sum of 3 quarters · filed 2018-03-14 | -$73.42M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-03-31 | -$33.13M 10-Q · filed 2017-05-09 | -$47.26M derived: sum of 2 quarters · filed 2018-03-14 | -$55.44M derived: sum of 3 quarters · filed 2018-03-14 | -$70.72M derived: sum of 4 quarters · filed 2018-03-14 |
| 2015-12-31 | -$14.13M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -$22.30M derived: sum of 2 quarters · filed 2018-03-14 | -$37.58M derived: sum of 3 quarters · filed 2018-03-14 | -$37.61M 10-K · filed 2018-03-14 |
| 2015-09-30 | -$8.18M 10-Q · filed 2016-11-08 | -$23.45M derived: sum of 2 quarters · filed 2016-11-08 | -$23.48M 10-Q · filed 2016-11-08 | |
| 2015-06-30 | -$15.28M 10-Q · filed 2016-08-09 | -$15.31M 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | -$28.00K 10-Q · filed 2016-05-10 | |||
| 2014-12-31 | $19.68M 10-K · filed 2017-03-13 |